Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey S Weber

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Cancer Journal (Sudbury, Mass.)|November 21, 2015
From the Guest Editor: Adoptive Cell Therapy: Fulfilling Its PromiseJeffrey S Weber
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
Immunotherapy in the adjuvant setting for high-risk melanomaJeffrey S Weber
Cancer Journal (Sudbury, Mass.)|August 10, 2010
From the guest editor: introduction for immunotherapy of cancerJeffrey S Weber
Journal of Leukocyte Biology|April 16, 2014
At the bedside: adoptive cell therapy for melanoma-clinical developmentJeffrey S Weber
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Challenging Cases: Management of Immune-Related ToxicityJeffrey S Weber
Melanoma Research|October 3, 2006
The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodiesJeffrey S Weber
Seminars in Oncology|December 3, 2014
Immuno-oncology comes of age-introductionJeffrey S Weber
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Biomarkers for Checkpoint InhibitionJeffrey S Weber
Annals of Surgical Oncology|October 26, 2005
Tumor regression and autoimmunity in cytotoxic T lymphocyte-associated antigen 4 blockade-treated patientsJeffrey S Weber
The Journal of Investigative Dermatology|November 11, 2008
Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanomaJeffrey S Weber
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Cancer Journal (Sudbury, Mass.)|November 21, 2015
From the Guest Editor: Adoptive Cell Therapy: Fulfilling Its PromiseJeffrey S Weber
Clinical Advances in Hematology & Oncology : H&O|August 28, 2018
Immunotherapy in the adjuvant setting for high-risk melanomaJeffrey S Weber
Cancer Journal (Sudbury, Mass.)|August 10, 2010
From the guest editor: introduction for immunotherapy of cancerJeffrey S Weber
Journal of Leukocyte Biology|April 16, 2014
At the bedside: adoptive cell therapy for melanoma-clinical developmentJeffrey S Weber
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Challenging Cases: Management of Immune-Related ToxicityJeffrey S Weber
Melanoma Research|October 3, 2006
The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodiesJeffrey S Weber
Seminars in Oncology|December 3, 2014
Immuno-oncology comes of age-introductionJeffrey S Weber
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Biomarkers for Checkpoint InhibitionJeffrey S Weber
Annals of Surgical Oncology|October 26, 2005
Tumor regression and autoimmunity in cytotoxic T lymphocyte-associated antigen 4 blockade-treated patientsJeffrey S Weber
The Journal of Investigative Dermatology|November 11, 2008
Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanomaJeffrey S Weber
Pageof 20